Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (188)

« Back to Publications

A Decision-Support System to Personalize Antidepressant Treatment in Major Depressive Disorder: A Randomized Clinical Trial.

Cipriani A. et al, (2026), JAMA

Economic evaluations in the palliative and end-of-life care settings: A systematic review of existing evidence, methods and quality.

Fischer C. et al, (2026), Palliat Med

Follow-up of suspected child maltreatment cases treated at a tertiary child protection service facility.

Mora-Theuer EA. et al, (2026), Eur J Pediatr, 185

Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation: economic evaluation of the PAX-D randomised controlled trial.

Łaszewska A. et al, (2026), Lancet Reg Health Eur, 61

Theoretically Universal, Practically Unequal: Socio-Economic Inequalities in Healthcare Access for Long Covid-19 Patients in Austria.

Gamillscheg-Müllner P. et al, (2026), Health Expect, 29

Translation, cross-cultural adaptation, and validation of the Caregiver Indirect and Informal Care Cost Assessment Questionnaire for end-of-life care into Spanish.

Lamfre LS. et al, (2026), Palliat Support Care, 24

Association between health literacy and reproductive health knowledge and behavior : A cross-sectional survey among women of reproductive age in Vienna.

Rottjakob P. et al, (2026), Wien Klin Wochenschr

Cost-effectiveness of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression: Economic evaluation of the PAX-BD randomised controlled trial.

Berger M. et al, (2025), J Affect Disord, 391

Barriers, facilitators, and the role of central coordination: understanding long COVID-19 healthcare access in a universal healthcare system.

Gamillscheg-Müllner P. et al, (2025), Arch Public Health, 83

Climate change and mental health: announcing a new Lancet Psychiatry Commission.

Brandt L. et al, (2025), Lancet Psychiatry, 12, 811 - 813

Psychometric properties of the ICECAP-SCM capability-wellbeing measure in specialist palliative care units in Austria.

Saly E. et al, (2025), Qual Life Res, 34, 2821 - 2833

The Use of EQ-5D in the Middle East and North Africa Region: A Systematic Literature Review.

Al Rabayah A. et al, (2025), Pharmacoeconomics, 43, 859 - 877

Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK.

Browning M. et al, (2025), Lancet Psychiatry, 12, 579 - 589

Non-mental health inpatient and emergency care hospital costs associated with four mental disorders in Europe: a modelling study.

Wienand D. et al, (2025), Lancet Psychiatry, 12, 513 - 523

Healthcare professionals' perspectives on assessing selected patient-reported outcome measures in specialist palliative care institutions: a multi-country mixed-methods study.

Saly E. et al, (2025), BMC Palliat Care, 24

Load More

1
2
3
4
5
6
7
...
»